Dodson S F, Issa S, Araya V, Gayowski T, Pinna A, Eghtesad B, Iwatsuki S, Montalvo E, Rakela J, Fung J J
Thomas E. Starzl Transplantation Institute, Pittsburgh, Pennsylvania 15213, USA.
Transplantation. 1997 Dec 15;64(11):1582-4. doi: 10.1097/00007890-199712150-00013.
Since suitable recipients for hepatic allografts from donors with antibodies to hepatitis B virus (HBV) have not been determined, a review of our 7-year experience with donors positive for hepatitis B surface antibody (anti-HBs), hepatitis B core antibody (anti-HBc), or both was undertaken.
Recipients of hepatic allografts from donors with antibodies to HBV were identified by a retrospective review of procurement records and screened for HBV infection.
From January 1, 1990, to January 1, 1997, 2578 liver transplants were performed and 140 (5.4%) recipients received an allograft from a donor with antibodies to HBV. Twenty-five of 48 recipients of a hepatic allograft from a donor positive only for anti-HBs were screened and none developed HBV infection. Twenty-five of 41 naive recipients of a hepatic allograft from an anti-HBc positive donor were screened and 18/25 (72%) developed HBV infection. Four of these 18 naive recipients with HBV infection received an allograft from a donor positive for both anti-HBc and anti-HBs. Seven of 13 anti-HBs-positive recipients of an allograft from an anti-HBc-positive donor were screened and none developed HBV infection. Fifteen of 16 recipients positive only for anti-HBc who received a hepatic allograft from an anti-HBc-positive donor were screened and 2/15 (13%) developed HBV infection.
Hepatic allografts from donors positive only for anti-HBs do not transmit HBV infection. Hepatic allografts from anti-HBc-positive donors frequently transmit HBV infection to naive recipients regardless of the donor anti-HBs status, and antiviral prophylaxis may be indicated. Anti-HBs-positive recipients appear resistant to HBV infection after orthotopic liver transplantation with an allograft from an anti-HBc-positive donor. Recipients positive only for anti-HBc infrequently develop HBV infection when transplanted with an allograft from an anti-HBc-positive donor; however, HBV prophylaxis may be justified.
由于尚未确定对乙型肝炎病毒(HBV)有抗体的供体肝脏移植的合适受者,我们对7年中乙型肝炎表面抗体(抗-HBs)、乙型肝炎核心抗体(抗-HBc)或两者均呈阳性的供体进行了回顾性研究。
通过回顾性查阅获取记录,确定接受过对HBV有抗体的供体肝脏移植的受者,并对其进行HBV感染筛查。
从1990年1月1日至1997年1月1日,共进行了2578例肝移植手术,其中140例(5.4%)受者接受了来自对HBV有抗体的供体的同种异体移植物。对48例仅抗-HBs阳性供体的肝移植受者中的25例进行了筛查,无一例发生HBV感染。对41例初次接受抗-HBc阳性供体肝移植的受者中的25例进行了筛查,其中18/25(72%)发生了HBV感染。这18例初次感染HBV的受者中有4例接受了抗-HBc和抗-HBs均阳性供体的移植物。对13例抗-HBc阳性供体的抗-HBs阳性受者中的7例进行了筛查,无一例发生HBV感染。对16例仅抗-HBc阳性且接受抗-HBc阳性供体肝移植的受者中的15例进行了筛查,其中2/1(13%)发生了HBV感染。
仅抗-HBs阳性供体的肝脏移植物不会传播HBV感染。抗-HBc阳性供体的肝脏移植物无论供体抗-HBs状态如何,都经常将HBV感染传播给初次接受移植的受者,可能需要进行抗病毒预防。抗-HBs阳性受者在接受抗-HBc阳性供体的原位肝移植后似乎对HBV感染有抵抗力。仅抗-HBc阳性的受者在接受抗-HBc阳性供体的移植物移植时很少发生HBV感染;然而,HBV预防可能是合理的。